PolitiKit

Promoting access to oral health care for Canada's denture users, including but not limited to those living in long-term care facilities, First Nations and Inuit people, Northern Canadians, and other vulnerable populations.

Recommending the addition of a new category within Canadian Mortgage and Housing Corporation's (CMHC) Mortgage Loan Insurance (MLI) Select Program.

Recommending reforming income verification rules at the Office of the Superintendent of Financial Institutions

Recommending reforming income verification rules at the Office of the Superintendent of Financial Institutions

Recommending reforming income verification rules at the Office of the Superintendent of Financial Institutions

CAOT is advocating for the inclusion of occupational therapists (OTs) on primary care teams in communities across Canada, so that OTs can provide low-cost, high-impact interventions that result in positive health and wellness outcomes for the people of Canada. OTs provide home assessments and modifications that allow seniors for example to stay at home and lead productive lives in their communities.

The inclusion of occupational therapists on all Primary Care Teams in communities across Canada re health system innovation and transformation. Advocating for OTs to be designated mental health providers.

CAOT is advocating for changes to the Income Tax Act or its regulations to enable occupational therapists to complete the T2201 Disability Tax Credit Certificate.

HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, Canada Student Grant, PGWP for dental assistants, internationally trained dentists, administrative staffing.

DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan and the Interim Federal Health Program.

Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.

DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan.

HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, internationally trained dentists, administrative staffing.

Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.

FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.

FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.

DIGITAL HEALTH: Increased investment in providing digital, virtual and telehealth services.

Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs related to rare diseases.

Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector

Free Trade agreements as they relate to the biopharmaceutical industry

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations.

Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.

Canada's Drug Agency (CDA) policies as it relates to health economics assessment and recommendations made on new medicines.

Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.

Discussions with government officials concerning veterinary medicine as it relates to workforce shortages and mental health of veterinarians.

Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.

Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.

International trade and tariffs. Particularly related to U.S. tariffs placed on Canadian products, as well as U.S. products subject to counter tariffs imposed by the Canadian government.